TTM-2 trial. Therapeutic hypothermia after cardiac arrest - Past, present & future
Cardio-Ed
English - June 18, 2021 15:30 - 12 minutes - 8.96 MB - ★★★★★ - 1 ratingMedicine Health & Fitness cardiology interventional cardiology echocardiography clinical trials medicine structural heart disease heart failure arrhythmia myocardial infarction cardiomyopathy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) - What works and what doesn't in 2021
Next Episode: In stent restenosis
Past, present and future of therapeutic hypothermia.
Targeted temperature management (TTM) or Therapeutic hypothermia is recommended for patients after cardiac arrest, but the supporting evidence is of low certainty.
TTM-2 trial was recently published in NEJM (June 2021).
The TTM-2 trial tried to answer the question if Therapeutic hypothermia is any better than normal temperature in patients who are in coma after being resuscitated from cardiac arrest.
I have briefly discussed the trial, also touching briefly the recent and upcoming trials of hypothermia protocol.
Do watch/ listen.
Follow Cardio-Ed for more content.